NASDAQ:ECOR

electroCore Stock Forecast, Price & News

$1.62
+0.03 (+1.89 %)
(As of 06/21/2021 10:50 AM ET)
Add
Compare
Today's Range
$1.59
$1.62
50-Day Range
$1.50
$1.94
52-Week Range
$0.77
$3.63
Volume202 shs
Average Volume2.52 million shs
Market Capitalization$78.64 million
P/E RatioN/A
Dividend YieldN/A
Beta1.31
30 days | 90 days | 365 days | Advanced Chart
Receive ECOR News and Ratings via Email

Sign-up to receive the latest news and ratings for electroCore and its competitors with MarketBeat's FREE daily newsletter.


electroCore logo

About electroCore

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.41 out of 5 stars

Medical Sector

704th out of 2,100 stocks

Electromedical Equipment Industry

15th out of 61 stocks

Analyst Opinion: 3.5Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











electroCore (NASDAQ:ECOR) Frequently Asked Questions

Is electroCore a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" electroCore stock.
View analyst ratings for electroCore
or view top-rated stocks.

What stocks does MarketBeat like better than electroCore?

Wall Street analysts have given electroCore a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but electroCore wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting electroCore?

electroCore saw a increase in short interest in May. As of May 14th, there was short interest totaling 1,020,000 shares, an increase of 36.0% from the April 29th total of 750,000 shares. Based on an average daily trading volume, of 3,190,000 shares, the days-to-cover ratio is currently 0.3 days.
View electroCore's Short Interest
.

When is electroCore's next earnings date?

electroCore is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for electroCore
.

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) announced its earnings results on Thursday, May, 6th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.01. The business had revenue of $1.20 million for the quarter, compared to the consensus estimate of $1.10 million. electroCore had a negative trailing twelve-month return on equity of 83.12% and a negative net margin of 527.89%.
View electroCore's earnings history
.

How has electroCore's stock price been impacted by COVID-19 (Coronavirus)?

electroCore's stock was trading at $0.5874 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ECOR shares have increased by 170.7% and is now trading at $1.59.
View which stocks have been most impacted by COVID-19
.

What guidance has electroCore issued on next quarter's earnings?

electroCore issued an update on its second quarter 2021 earnings guidance on Tuesday, June, 1st. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $1.20 M-, compared to the consensus revenue estimate of $1.28 million.

What price target have analysts set for ECOR?

4 brokerages have issued 1 year target prices for electroCore's shares. Their forecasts range from $3.00 to $5.00. On average, they expect electroCore's share price to reach $3.63 in the next year. This suggests a possible upside of 128.0% from the stock's current price.
View analysts' price targets for electroCore
or view top-rated stocks among Wall Street analysts.

Who are electroCore's key executives?

electroCore's management team includes the following people:
  • Mr. Daniel S. Goldberger, CEO & Director (Age 62, Pay $919.64k)
  • Mr. Joseph P. Errico, Co-Founder, Principal Investor & Director (Age 52)
  • Mr. Brian M. Posner, CFO & Corp. Sec. (Age 59, Pay $601.62k)
  • Mr. Michael Romaniw, Exec. VP of Systems & Operations (Age 64)
  • Ms. Jackie Dorsky, VP of Marketing
  • Mr. Iain Strickland Ph.D., VP of Global Sales & Strategy
  • Ms. Carrie Kochek, Sr. Director of HR
  • Dr. Peter S. Staats, Chief Medical Officer (Age 57)
  • Mr. Eric J. Liebler, Sr. VP of Neurology (Age 57)

Who are some of electroCore's key competitors?

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

When did electroCore IPO?

(ECOR) raised $64 million in an initial public offering (IPO) on Friday, June 22nd 2018. The company issued 4,300,000 shares at $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

What is electroCore's stock symbol?

electroCore trades on the NASDAQ under the ticker symbol "ECOR."

Who are electroCore's major shareholders?

electroCore's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Valeo Financial Advisors LLC (2.98%), Geode Capital Management LLC (0.99%), Renaissance Technologies LLC (0.45%), GSA Capital Partners LLP (0.30%), Jaffetilchin Investment Partners LLC (0.26%) and Laurion Capital Management LP (0.19%). Company insiders that own electroCore stock include James L L Tullis, John P Gandolfo and Thomas J Errico.
View institutional ownership trends for electroCore
.

Which major investors are selling electroCore stock?

ECOR stock was sold by a variety of institutional investors in the last quarter, including Hussman Strategic Advisors Inc., Valeo Financial Advisors LLC, Laurion Capital Management LP, Squarepoint Ops LLC, and GSA Capital Partners LLP.
View insider buying and selling activity for electroCore
or view top insider-selling stocks.

Which major investors are buying electroCore stock?

ECOR stock was acquired by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Renaissance Technologies LLC, Jaffetilchin Investment Partners LLC, Citadel Advisors LLC, Citadel Advisors LLC, Virtu Financial LLC, Dimensional Fund Advisors LP, and United Asset Strategies Inc.. Company insiders that have bought electroCore stock in the last two years include James L L Tullis, John P Gandolfo, and Thomas J Errico.
View insider buying and selling activity for electroCore
or or view top insider-buying stocks.

How do I buy shares of electroCore?

Shares of ECOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is electroCore's stock price today?

One share of ECOR stock can currently be purchased for approximately $1.59.

How much money does electroCore make?

electroCore has a market capitalization of $77.18 million and generates $3.50 million in revenue each year. The company earns $-23,510,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis.

How many employees does electroCore have?

electroCore employs 45 workers across the globe.

What is electroCore's official website?

The official website for electroCore is www.electrocore.com.

Where are electroCore's headquarters?

electroCore is headquartered at 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920.

How can I contact electroCore?

electroCore's mailing address is 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920. The company can be reached via phone at 973-290-0097 or via email at [email protected]


This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.